Alembic Pharma gets USFDA nod for Paliperidone extended-release Tablets

Alembic Pharmaceuticals has announced that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Paliperidone extended-release tablets.